Reviews sharpen the case for functional ingredients in pet food

A new review in Veterinary Research Communications suggests the pet food sector is entering a more mature phase in how it talks about functional nutrition. Rather than treating “functional ingredients” as a loose marketing label, the authors propose clearer definitions for functional ingredients, bioactive compounds, and dietary supplements in companion animals, then map available evidence across 11 clinical and physiologic domains relevant to dogs and cats. The review positions these ingredients as potential tools to support healthspan and reduce disease risk through diet, not just through traditional therapeutic interventions. (eurekamag.com)

That framing lands at a time when the commercial pet food market has been steadily adding probiotics, prebiotics, fiber blends, omega-3s, yeast derivatives, botanicals, and plant extracts to complete diets, toppers, and supplements. A parallel review in Animals shows how fast the plant-derived side of the category is expanding, with attention on polyphenols, microalgae, plant extracts, and cannabinoids for antioxidant, anti-inflammatory, immunomodulatory, and microbiome-related effects. Broader recent literature also points to rising product development activity around probiotics and other bioactives, especially in premium and condition-specific formulations. (pmc.ncbi.nlm.nih.gov)

The new Veterinary Research Communications review covers a wide range of ingredient classes already appearing in commercial pet foods: probiotics, prebiotics, metabiotics, exogenous enzymes, omega-3 fatty acids, antioxidants, and plant extracts. According to the indexed summary, the authors examine mechanisms, physiologic effects, and clinical evidence tied to digestive health, skin and coat condition, musculoskeletal support, oral health, behavior and mood, immune regulation, cognitive function, obesity management, cardiovascular regulation, liver protection, and urinary and renal health. That breadth is notable because it reflects where pet food innovation is heading: away from single-nutrient adequacy alone and toward ingredients marketed for targeted physiologic outcomes. (eurekamag.com)

Still, the supporting evidence remains mixed depending on the ingredient and indication. Some categories have more usable data than others. For example, a controlled study in adult dogs found that diets containing a fiber-prebiotic-probiotic blend were associated with improved stool quality, favorable shifts in fecal bacteria and metabolites, and signs of enhanced gut immune function. Separately, a systematic review and meta-analysis of enriched diets and nutraceuticals in canine and feline osteoarthritis found the clearest clinical analgesic signal for omega-3-enriched diets and omega-3 supplements, with more limited support for cannabidiol. Those findings help explain why gut-health blends and omega-3 positioning continue to dominate product claims. (pmc.ncbi.nlm.nih.gov)

But the literature also contains repeated cautions. Reviews of botanicals and specialty plant compounds note that many ingredients look promising mechanistically, yet lack robust, species-specific clinical trials in dogs and cats. Another review on Astragalus and ginseng in pet diets goes further, warning that without stronger evidence, some products may function more as marketing vehicles than clinically meaningful interventions. Quality control is another recurring issue: older work found that probiotic claims in pet foods did not always align with what products actually contained, and more recent reviews continue to emphasize challenges around strain selection, viability through processing, and post-extrusion delivery. (pmc.ncbi.nlm.nih.gov)

Why it matters: For veterinary professionals, this is less a story about a single breakthrough than about a category maturing. Pet parents are increasingly exposed to foods marketed around gut health, inflammation, cognition, mobility, skin support, or immune balance, and these reviews give clinicians a clearer framework for evaluating those claims. The practical message is that some functional ingredients may have real value, especially where there is controlled feeding data, but the label “functional” shouldn’t be mistaken for proven efficacy. Species differences, nutrient interactions, palatability, processing losses, dose-response effects, and long-term safety all still matter in clinical recommendations. (eurekamag.com)

That matters even more in cats, where nutritional constraints are narrower and extrapolation from canine or human data can be risky. Reviews of plant-based and plant-derived strategies repeatedly flag nutrient adequacy concerns around taurine, arachidonic acid, vitamin B12, vitamin D, sulfur amino acids, and omega-3 fatty acids when diets move too far from established formulations without careful balancing. Even when a bioactive ingredient appears beneficial on its own, the full diet context remains critical. (pmc.ncbi.nlm.nih.gov)

What to watch: The next phase will likely be defined by better clinical substantiation, not more ingredient novelty: more randomized feeding trials in client-owned dogs and cats, tighter quality standards for live or fragile bioactives, and sharper distinctions between ingredients that support general wellness claims and those that can credibly influence disease management. (pmc.ncbi.nlm.nih.gov)